Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection
The only US licensed vaccine with established efficacy against smallpox, Dryvax, is contraindicated for HIV patients. Detectable smallpox-neutralizing antibodies are still present among US adults. This study compared vaccinia-neutralizing antibody titers between 20 HIV-infected and 20 uninfected veterans matched for age and military entry. Vaccinia-neutralizing antibodies were detected in 95% HIV-infected and 100% uninfected veterans; 40% HIV-infected and 70% uninfected adults had protective titers. Therefore, after robust vaccination, neutralizing antibodies are maintained for prolonged times despite CD4 cell depletion. © 2007 Lippincott Williams & Wilkins, Inc.
Kan, V., Manischewitz, J., King, L., & Golding, H. (2007). Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection. AIDS, 21 (4). http://dx.doi.org/10.1097/QAD.0b013e32802f7d7c